Elena Conca

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Journal: Tumori

Published: June 24, 2026

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Journal: Pediatric blood & cancer

Published: January 16, 2026

Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.

Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.

Journal: The Journal of pathology

Published: January 15, 2026

Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Journal: JCO precision oncology

Published: September 26, 2025

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 05, 2025

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

Journal: ESMO open

Published: August 09, 2025

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Journal: JCO precision oncology

Published: June 11, 2025

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Journal: Frontiers in oncology

Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open

Published: May 16, 2025

Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?

Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?

Journal: Tumori

Published: September 23, 2024

Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples.

Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples.

Journal: Scientific reports

Published: September 13, 2024

Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.

Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026